Scarica l'app Stockscreener
2.00
0.00%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.00
Aprire:
$2
Volume 24 ore:
16,107
Relative Volume:
0.22
Capitalizzazione di mercato:
$23.15M
Reddito:
$3.02M
Utile/perdita netta:
$-653.00K
Rapporto P/E:
-40.57
EPS:
-0.0493
Flusso di cassa netto:
$2.42M
1 W Prestazione:
-9.91%
1M Prestazione:
-10.71%
6M Prestazione:
+88.68%
1 anno Prestazione:
+100.00%
Intervallo 1D:
$1.9401
$2.05
Intervallo di 1 settimana:
$1.90
$2.27
Portata 52W:
$0.84
$2.95
Therapeuticsmd Inc Stock (TXMD) Company Profile
Nome
Therapeuticsmd Inc
Settore
Telefono
561-961-1900
Indirizzo
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
2.00 | 23.15M | 3.02M | -653.00K | 2.42M | -0.0493 |
TAK
Takeda Pharmaceutical Co Adr
|
18.74 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
117.94 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.93 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.08 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
564.81 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-08-07 | Downgrade | Jefferies | Hold → Underperform |
| 2020-05-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Iniziato | Guggenheim | Buy |
| 2019-10-17 | Iniziato | H.C. Wainwright | Buy |
| 2019-04-30 | Ripresa | Noble Capital Markets | Outperform |
| 2018-06-15 | Iniziato | JP Morgan | Overweight |
| 2017-09-08 | Iniziato | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Ripresa | Jefferies | Buy |
| 2016-11-22 | Iniziato | Oppenheimer | Outperform |
| 2016-11-07 | Ripresa | Guggenheim | Buy |
| 2016-04-04 | Iniziato | Goldman | Buy |
| 2015-12-08 | Reiterato | Jefferies | Buy |
| 2015-12-08 | Reiterato | Stifel | Buy |
| 2015-09-21 | Reiterato | Jefferies | Buy |
| 2015-06-09 | Iniziato | Guggenheim | Buy |
| 2014-07-08 | Iniziato | FBR Capital | Outperform |
| 2014-04-17 | Reiterato | Noble Financial | Buy |
| 2014-01-28 | Reiterato | Noble Financial | Buy |
Mostra tutto
Therapeuticsmd Inc Borsa (TXMD) Ultime notizie
TherapeuticsMD Inc. (TXMD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
TherapeuticsMD Inc. R (29TA.F) stock price, news, quote and history - uk.finance.yahoo.com
TherapeuticsMD Explains Brief Delay In Annual Filing - The Globe and Mail
TherapeuticsMD 2025 Annual Report: Business Overview, Risk Factors, and Intellectual Property Challenges - Minichart
[10-K/A] TherapeuticsMD, Inc. Amends Annual Report - stocktitan.net
TherapeuticsMD Inc. stock rises Tuesday, still underperforms market - MarketWatch
TherapeuticsMD Announces Full Year 2025 Financial Results - BioSpace
TherapeuticsMD (NASDAQ: TXMD) files 2025 Form 10-K after printer error - stocktitan.net
TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy - TipRanks
TXMD Reports $7.5 Million in Cash Holdings as of Year-End 2025 - GuruFocus
TXMD: Net loss narrowed and license revenue surged as strategic alternatives are explored - TradingView
TXMD: 2025 saw improved results from royalty revenue, but litigation and liquidity risks threaten viability - TradingView
TherapeuticsMD (NASDAQ: TXMD) reports 2025 results, weighs strategic options - stocktitan.net
[10-K] TherapeuticsMD, Inc. Files Annual Report - Stock Titan
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TXMD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Lumentum Holdings Leads Six-Month Stock Performance with 425.03% Return - Markets Mojo
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
Insider Trends: Whats next for TherapeuticsMD Inc stockQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Market Overview: Whats next for TherapeuticsMD Inc stockEarnings Growth Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
Lumentum Holdings Leads Stock Performance with 311.87% Return in Six Months - Markets Mojo
If You Invested $1,000 in Therapeuticsmd Inc (TXMD) - stocktitan.net
Investment Report: Is TherapeuticsMD Inc forming a double bottom2026 Winners & Losers & High Conviction Buy Zone Alerts - baoquankhu1.vn
Breakout Move: Is TherapeuticsMD Inc stock a falling knife or bargain buy2025 Analyst Calls & Smart Investment Allocation Tips - baoquankhu1.vn
TXMD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Volatility Watch: Is TherapeuticsMD Inc stock heavily shortedJuly 2025 Intraday Action & Stepwise Swing Trade Plans - baoquankhu1.vn
TXMD PE Ratio & Valuation, Is TXMD Overvalued - Intellectia AI
Should I hold or sell BTC Digital Ltd nowEarnings Overview Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
Is TherapeuticsMD Inc. forming a double bottom2025 Key Lessons & Weekly Momentum Picks - mfd.ru
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
What are analysts’ price targets for TherapeuticsMD Inc.Market Trend Report & Fast Exit and Entry Strategy Plans - mfd.ru
Is TherapeuticsMD Inc. stock a buy or sell2025 Retail Activity & Daily Profit Maximizing Trade Tips - mfd.ru
Aug Breakouts: Can JetAI Inc be the next market leaderWeekly Gains Report & Risk Managed Investment Signals - baoquankhu1.vn
Should you buy the dip on TherapeuticsMD Inc.Dividend Hike & Daily Momentum Trading Reports - mfd.ru
Why TherapeuticsMD Inc. stock could rally in 2025Breakout Watch & High Conviction Investment Ideas - bollywoodhelpline.com
Momentum Shift: Is TherapeuticsMD Inc stock a falling knife or bargain buyGap Down & Weekly High Return Stock Opportunities - baoquankhu1.vn
Is TherapeuticsMD Inc forming a double bottomEarnings Trend Report & Reliable Trade Execution Plans - baoquankhu1.vn
Sell Signal: What is the fair value of TherapeuticsMD Inc stock nowMarket Performance Report & Verified Momentum Stock Watchlist - Bộ Nội Vụ
Gains Recap: Why retail investors pile into TherapeuticsMD Inc stockRate Hike & Daily Volume Surge Signals - Bộ Nội Vụ
Institution Moves: How strong is TherapeuticsMD Inc stock revenue growthJuly 2025 Outlook & Reliable Entry Point Alerts - Bộ Nội Vụ
TherapeuticsMD Reports Q3 2025 Financial Results - MSN
Why TherapeuticsMD Inc. stock could be next big winnerShare Buyback & Accurate Buy Signal Alerts - Улправда
Is TherapeuticsMD Inc. stock a buy for dividend growthCPI Data & Weekly Setup with ROI Potential - Улправда
Will TherapeuticsMD Inc. stock continue upward momentum2025 Trade Ideas & Stepwise Trade Execution Plans - Улправда
Is TherapeuticsMD Inc. stock a safe haven asset2025 Performance Recap & Free Community Consensus Stock Picks - Улправда
Can TherapeuticsMD Inc. stock rebound after recent weaknessChart Signals & Smart Investment Allocation Tips - Улправда
Can TherapeuticsMD Inc. stock deliver strong Q4 earningsJuly 2025 EndofMonth & Community Trade Idea Sharing - Улправда
Chart Watch: Can TherapeuticsMD Inc. stock deliver strong Q4 earningsQuarterly Profit Report & Weekly Top Gainers Trade List - Улправда
How strong is TherapeuticsMD Inc. stock revenue growthTreasury Yields & Technical Pattern Recognition Alerts - Улправда
Therapeuticsmd Inc Azioni (TXMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Therapeuticsmd Inc Azioni (TXMD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thompson Tommy G | Director |
Apr 14 '25 |
Buy |
1.00 |
325 |
326 |
14,779 |
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):